{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T11:18:08Z","timestamp":1761823088021},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2008,11,18]],"date-time":"2008-11-18T00:00:00Z","timestamp":1226966400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Calcif Tissue Int"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1007\/s00223-008-9187-5","type":"journal-article","created":{"date-parts":[[2008,11,17]],"date-time":"2008-11-17T15:53:25Z","timestamp":1226937205000},"page":"393-403","source":"Crossref","is-referenced-by-count":9,"title":["Bone Parameters are Improved with Intermittent Dosing of Vitamin D3 and Calcitonin"],"prefix":"10.1007","volume":"83","author":[{"given":"C. J.","family":"Andresen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Moalli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. H.","family":"Turner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Berryman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Pero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. M.","family":"Bagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,11,18]]},"reference":[{"key":"9187_CR1","first-page":"690","volume":"14","author":"DW Dempster","year":"1993","unstructured":"Dempster DW, Cosman F, Parisien M, Shen V, Lindsay R (1993) Anabolic actions of parathyroid hormone on bone. Endocr Rev 14:690\u2013709","journal-title":"Endocr Rev"},{"key":"9187_CR2","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1210\/endo.132.4.8462456","volume":"132","author":"DB Kimmel","year":"1993","unstructured":"Kimmel DB, Bozzato RP, Kronis KA, Coble T, Sindrey D, Kwong P, Recker RR (1993) The effect of recombinant human (1\u201384) or synthetic human (1\u201334) parathyroid hormone on the skeleton of adult osteopenic ovariectomized rats. Endocrinology 132:1577\u20131584","journal-title":"Endocrinology"},{"key":"9187_CR3","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1001\/archinte.162.20.2297","volume":"16","author":"C Crandall","year":"2002","unstructured":"Crandall C (2002) Parathyroid hormone for treatment of osteoporosis. Arch Intern Med 16:2297\u20132309","journal-title":"Arch Intern Med"},{"key":"9187_CR4","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1056\/NEJMoa050336","volume":"353","author":"DM Black","year":"2005","unstructured":"Black DM, Bilezikian JP, Ensrud KE, Greenspan SL, Palermo L, Hue T, Lang TF, McGowan JA, Rosen CJ (2005) One year of alendronate after one year of parathyroid hormone (1\u201384) for osteoporosis. N Engl J Med 353:555\u2013565","journal-title":"N Engl J Med"},{"key":"9187_CR5","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1056\/NEJMoa031975","volume":"25","author":"DM Black","year":"2003","unstructured":"Black DM, Greenspan SL, Ensrud KE, Palermo L, McGowen JA, Lang TF, Garnero P, Bouxsein ML, Bilezikian JP, Rosen CJ (2003) The effects of parathyroid hormone and alendronate alone or in combination in postemenopausal osteoporosis. N Engl J Med 25:1207\u20131215","journal-title":"N Engl J Med"},{"key":"9187_CR6","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1056\/NEJMoa035725","volume":"25","author":"JS Finkelstein","year":"2003","unstructured":"Finkelstein JS, Hayes A, Hunzelman JL, Wyland JJ, Lee H, Neer RM (2003) The effects of parathyroid hormone, alendronate, or both in men with osteoporosis. N Engl J Med 25:1216\u20131226","journal-title":"N Engl J Med"},{"key":"9187_CR7","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/8756-3282(95)00113-R","volume":"16","author":"PD Delmas","year":"1995","unstructured":"Delmas PD, Vergnaud P, Arlot ME, Pastoureau P, Meunier PJ, Nilssen MH (1995) The anabolic effect of human PTH (1\u201334) on bone formation is blunted when bone resorption is inhibited by the bisphosphonate tiludronate\u2014is activated resorption a prerequisite for the in vivo effect of PTH on formation in a remodeling system? Bone 16:603\u2013610","journal-title":"Bone"},{"key":"9187_CR8","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/8756-3282(95)00115-T","volume":"16","author":"M Li","year":"1995","unstructured":"Li M, Li Mosekilde, S\u00f8gaard CH, Thomsen JS, Wronski TJ (1995) Parathyroid hormone monotherapy and cotherapy with antiresorptive agents restore vertebral bone mass and strength in aged ovariectomized rats. Bone 16:629\u2013635","journal-title":"Bone"},{"key":"9187_CR9","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/8756-3282(94)00036-Y","volume":"16","author":"BD Baumann","year":"1995","unstructured":"Baumann BD, Wronski TJ (1995) Response of cortical bone to antiresorptive agents and parathyroid hormone in aged ovariectomized rats. Bone 16:247\u2013253","journal-title":"Bone"},{"key":"9187_CR10","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.bone.2007.10.005","volume":"42","author":"R Rizzoli","year":"2008","unstructured":"Rizzoli R, Boonen S, Brandi ML, Burlet N, Delmas P, Reginster JY (2008) The role of calcium and vitamin D in the management of osteoporosis. Bone 42:246\u2013249","journal-title":"Bone"},{"key":"9187_CR11","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1172\/JCI29449","volume":"116","author":"MF Holick","year":"2006","unstructured":"Holick MF (2006) Resurrection of vitamin D deficiency and rickets. J Clin Invest 116:2062\u20132072","journal-title":"J Clin Invest"},{"key":"9187_CR12","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/BF02405028","volume":"35","author":"R Narbaitz","year":"1983","unstructured":"Narbaitz R, Stumpf WE, Sar M, Huang S, DeLuca HF (1983) Autoradiographic localization of target cells for 1\u03b1,25-dihydroxyvitamin D3 in bones from fetal rats. Calcif Tissue Int 35:177\u2013182","journal-title":"Calcif Tissue Int"},{"key":"9187_CR13","doi-asserted-by":"crossref","first-page":"4319","DOI":"10.1210\/endo.139.10.6249","volume":"139","author":"RG Erben","year":"1998","unstructured":"Erben RG, Bromm S, Stangassinger M (1998) Therapeutic efficacy of 1\u03b1,25-dihydroxyvitamin D3 and calcium in osteopenic ovariectomized rats: evidence for a direct anabolic effect of 1\u03b1,25-dihydroxyvitamin D3 on bone. Endocrinology 139:4319\u20134328","journal-title":"Endocrinology"},{"key":"9187_CR14","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.mam.2005.01.005","volume":"26","author":"M Montero-Odasso","year":"2005","unstructured":"Montero-Odasso M, Duque G (2005) Vitamin D in the aging musculoskeletal system: an authentic strength preserving hormone. Mol Aspects Med 26:203\u2013219","journal-title":"Mol Aspects Med"},{"key":"9187_CR15","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1138\/20060217","volume":"3","author":"WJ Pike","year":"2006","unstructured":"Pike WJ (2006) New steroidal vitamin D receptor modulators: are these ligands the real deal? BoneKEy Osteovision 3:14\u201318","journal-title":"BoneKEy Osteovision"},{"key":"9187_CR16","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S8756-3282(02)00688-9","volume":"30","author":"M Zaidi","year":"2002","unstructured":"Zaidi M, Inzerillo AM, Moonga BS, Bevis PJR, Huang CL-H (2002) Forty years of calcitonin\u2014where are we now? A tribute to the work of Iain Macintyre, FRS. Bone 30:655\u2013663","journal-title":"Bone"},{"issue":"Suppl","key":"9187_CR17","doi-asserted-by":"crossref","first-page":"63S","DOI":"10.1016\/S8756-3282(99)00068-X","volume":"24","author":"TJ Martin","year":"1999","unstructured":"Martin TJ (1999) Calcitonin, an update. Bone 24(Suppl):63S\u201365S","journal-title":"Bone"},{"key":"9187_CR18","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s00774-005-0613-8","volume":"23","author":"RA Davey","year":"2005","unstructured":"Davey RA, Morris HA (2005) The effects of salmon calcitonin-induced hypocalcemia on bone metabolism in ovariectomized rats. J Bone Miner Metab 23:359\u2013365","journal-title":"J Bone Miner Metab"},{"key":"9187_CR19","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1210\/endo.137.3.8603572","volume":"137","author":"S Wada","year":"1996","unstructured":"Wada S, Udagawa N, Nagata N et al (1996) Calcitonin receptor down-regulation relates to calcitonin resistance in mature mouse osteoclasts. Endocrinology 137:1042\u20131048","journal-title":"Endocrinology"},{"key":"9187_CR20","first-page":"109","volume-title":"Bone histomorphometry, techniques and interpretation","author":"HM Frost","year":"1983","unstructured":"Frost HM (1983) Bone histomorphometry: analysis of trabecular bone dynamics. In: Recker R (ed) Bone histomorphometry, techniques and interpretation. CRC Press, Boca Raton, FL, pp 109\u2013131"},{"key":"9187_CR21","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/jbmr.5650020617","volume":"2","author":"AM Parfitt","year":"1987","unstructured":"Parfitt AM, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR (1987) Bone histomorphometry nomenclature, symbols and units. J Bone Miner Res 2:595\u2013610","journal-title":"J Bone Miner Res"},{"key":"9187_CR22","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/ageing\/13.1.14","volume":"13","author":"RM Francis","year":"1984","unstructured":"Francis RM, Peacock M, Barkworth SA (1984) Renal impairment and its effects on calcium metabolism in elderly women. Age Aging 13:14\u201320","journal-title":"Age Aging"},{"key":"9187_CR23","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0026-0495(90)90272-E","volume":"39 Suppl 1","author":"A Cannigia","year":"1990","unstructured":"Cannigia A, Nuti R, Lore F, Martini G, Turchetti V, Righi G (1990) Long-term treatment with calcitriol in postmenopausal osteoporosis. Metabolism 39(Suppl 1):43\u201349","journal-title":"Metabolism"},{"key":"9187_CR24","first-page":"1052","volume":"80","author":"ME Ooms","year":"1995","unstructured":"Ooms ME, Roos JC, Bezemer PD, Van der Vijfh WJF, Bouther LM, Lips P (1995) Prevention of bone loss by vitamin D supplementation in elderly women: a randomized double-blind trial. J Clin Endocrinol Metab 80:1052\u20131058","journal-title":"J Clin Endocrinol Metab"},{"key":"9187_CR25","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1073\/pnas.79.10.3325","volume":"79","author":"JC Gallagher","year":"1982","unstructured":"Gallagher JC, Jerpbak CM, Jee WSS, Johnson KA, DeLuca HF, Riggs BL (1982) 1,25-Dihydroxyvitamin D3: short- and long-term effects on bone and calcium metabolism in patients with postmenopausal osteoporosis. Proc Natl Acad Sci USA 79:3325\u20133329","journal-title":"Proc Natl Acad Sci USA"},{"key":"9187_CR26","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3181\/00379727-191-42922","volume":"191","author":"JC Gallagher","year":"1989","unstructured":"Gallagher JC, Riggs BL, Recker RR, Goldgar D (1989) The effect of calcitriol on patients with postmenopausal osteoporosis with special reference to fracture frequency. Proc Soc Exp Biol Med 191:287\u2013292","journal-title":"Proc Soc Exp Biol Med"},{"key":"9187_CR27","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1056\/NEJM199202063260601","volume":"326","author":"M Tilyard","year":"1992","unstructured":"Tilyard M, Spears G, Thomson J, Dovey S (1992) Treatment of postmenopausal osteoporosis with calcitriol or calcium. N Engl J Med 326:357\u2013362","journal-title":"N Engl J Med"},{"key":"9187_CR28","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0169-6009(08)80003-7","volume":"20","author":"M Shiraki","year":"1993","unstructured":"Shiraki M, Itoh H, Orimo H (1993) The ultra long-term treatment of senile osteoporosis with 1 alpha-hydroxyvitamin D3. Bone Miner 20:223\u2013234","journal-title":"Bone Miner"},{"key":"9187_CR29","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1056\/NEJM199212033272305","volume":"327","author":"MC Chapuy","year":"1992","unstructured":"Chapuy MC, Arlot ME, Dubeuf F, Brun J, Crouzet B, Arnaud S, Delmas PD, Meunier PJ (1992) Vitamin D3 and calcium to prevent hip fractures in elderly women. N Engl J Med 327:1637\u20131642","journal-title":"N Engl J Med"},{"key":"9187_CR30","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1080\/01926230252929882","volume":"30","author":"JL Vahle","year":"2002","unstructured":"Vahle JL, Sato M, Long GG, Young JK, Francis PC, Engelhardt JA, Westmore MS, Linda Y, Nold JB (2002) Skeletal changes in rats given daily subcutaneous injections of recombinant human parathyroid hormone (1\u201334) for 2\u00a0years and relevance to human safety. Toxicol Pathol 30:312\u2013321","journal-title":"Toxicol Pathol"},{"key":"9187_CR31","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1124\/jpet.302.1.304","volume":"302","author":"M Sato","year":"2002","unstructured":"Sato M, Ma YL, Hock JM, Westmore MS, Vahle J, Villanueva A, Turner CH (2002) Skeletal efficacy with parathyroid hormone in rats was not entirely beneficial with long-term treatment. J Pharmacol Exp Ther 302:304\u2013313","journal-title":"J Pharmacol Exp Ther"},{"key":"9187_CR32","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1138\/20060248","volume":"4","author":"MR Allen","year":"2007","unstructured":"Allen MR, Burr DB (2007) Mineralization, microdamage, and matrix: how bisphosphonates influence material properties of bone. BoneKEy Osteovision 4:49\u201360","journal-title":"BoneKEy Osteovision"},{"key":"9187_CR33","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s002239900702","volume":"65","author":"KHW Lau","year":"1999","unstructured":"Lau KHW, Baylink D (1999) Vitamin D therapy of osteoporosis: plain vitamin D therapy versus active vitamin D analog (D-hormone) therapy. Calcif Tissue Int 65:295\u2013306","journal-title":"Calcif Tissue Int"},{"key":"9187_CR34","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1055\/s-0029-1211141","volume":"99","author":"H Devlin","year":"1992","unstructured":"Devlin H, Lumb G, Ferguson MWJ (1992) Serum parathyroid hormone and calcitonin levels following ovariectomy in the adult rat. Exp Clin Endocrinol 99:84\u201386","journal-title":"Exp Clin Endocrinol"},{"key":"9187_CR35","first-page":"267","volume":"109","author":"CH Chesnut III","year":"2000","unstructured":"Chesnut CHIII, Silverman S, Andriano K, Genant H, Gimona A, Harris S, Kiel D, LeBoff M, Maricic M, Miller P, Moniz C, Peacock M, Richardson P, Watts N, Baylink D (2000) A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study. PROOF Study Group. Am J Med 109:267\u2013276","journal-title":"PROOF Study group. Am J Med"},{"key":"9187_CR36","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1210\/edrv-8-4-377","volume":"8","author":"MT McDermott","year":"1987","unstructured":"McDermott MT, Kidd GS (1987) The role of calcitonin in the development and treatment of osteoporosis. Endocr Rev 8:377\u20133390","journal-title":"Endocr Rev"},{"key":"9187_CR37","doi-asserted-by":"crossref","first-page":"75S","DOI":"10.1016\/S8756-3282(02)00715-9","volume":"30","author":"J-J Body","year":"2002","unstructured":"Body J-J (2002) Calcitonin for the long-term prevention and treatment of postmenopausal osteoporosis. Bone 30:75S\u201379S","journal-title":"Bone"},{"key":"9187_CR38","doi-asserted-by":"crossref","first-page":"65S","DOI":"10.1016\/S8756-3282(02)00712-3","volume":"30","author":"JA Kanis","year":"2002","unstructured":"Kanis JA (2002) Calcitonin in osteoporosis. Bone 30:65S\u201366S","journal-title":"Bone"},{"key":"9187_CR39","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S8756-3282(99)00200-8","volume":"25","author":"S Wallach","year":"1999","unstructured":"Wallach S, Roussau G, Martin L, Azria M (1999) Effects of calcitonin on animal and in vitro models of skeletal metabolism. Bone 25:509\u2013516","journal-title":"Bone"},{"key":"9187_CR40","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1210\/endo.138.8.5383","volume":"138","author":"HM Kronenberg","year":"1997","unstructured":"Kronenberg HM (1997) Parathyroid hormone and osteocalcin\u2014when friends become strangers. Endocrinology 138:3083\u20133084","journal-title":"Endocrinology"},{"key":"9187_CR41","first-page":"446","volume":"243","author":"LG Raisz","year":"1972","unstructured":"Raisz LG, Wener JA, Trummel CL et al (1972) Induction, inhibition and escape as phenomenon in bone resorption. Excerpta Medica Int Cong Ser 243:446\u2013453","journal-title":"Excerpta Medica Int Cong Ser"},{"key":"9187_CR42","doi-asserted-by":"crossref","first-page":"643","DOI":"10.3181\/00379727-146-38163","volume":"146","author":"HH Messer","year":"1974","unstructured":"Messer HH, Copp DH (1974) Changes in response to calcitonin following prolonged administration to intact rats. Proc Soc Exp Biol Med 146:643\u2013647","journal-title":"Proc Soc Exp Biol Med"},{"key":"9187_CR43","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/8756-3282(90)90210-P","volume":"11","author":"K Tada","year":"1990","unstructured":"Tada K, Yamamuro T, Okumura H, Kasai R, Takahashi H (1990) Restoration of axial and apendicular bone volumes by h-PTH (1\u201334) in parathyreoidectomized and osteopenic rats. Bone 11:163\u2013169","journal-title":"Bone"},{"key":"9187_CR44","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1359\/JBMR.050205","volume":"20","author":"D Chappard","year":"2005","unstructured":"Chappard D, Retailleau-Gaborit N, Legrand E, Felix Basle M, Audran M (2005) Comparison insight bone measurements by histomorphometry and mCT. J Bone Miner Res 20:1177\u20131184","journal-title":"J Bone Miner Res"},{"key":"9187_CR45","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.bone.2008.01.029","volume":"42","author":"MA Miller","year":"2008","unstructured":"Miller MA, Bare SP, Recker RR, Smith SY, Fox J (2008) Intratrabecular tunneling increases trabecular number throughout the skeleton of ovariectomized rhesus monkeys treated with parathyroid hormone 1\u201384. Bone 42:1175\u20131183","journal-title":"Bone"},{"key":"9187_CR46","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/8756-3282(94)90322-0","volume":"15","author":"S Nishida","year":"1994","unstructured":"Nishida S, Yamaguchi A, Tanizawa T, Endo N, Mashiba T, Uchiyama Y, Suda T, Yoshiki S, Takahashi HE (1994) Increased bone formation by intermittent PTH administration is due to the simulation of proliferation and differentiation of osteoprogenitor cells in bone marrow. Bone 15:717\u2013723","journal-title":"Bone"},{"key":"9187_CR47","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1359\/jbmr.2001.16.8.1399","volume":"16","author":"TJ Wronski","year":"2001","unstructured":"Wronski TJ, Ratkus AM, Thomsen JS, Vulcan Q, Mosekilde L (2001) Sequential treatment with basic fibroblast growth factor and parathyroid hormone restores lost cancellous bone mass and strength in the proximal tibia of aged ovariectomized rats. J Bone Miner Res 16:1399\u20131407","journal-title":"J Bone Miner Res"},{"key":"9187_CR48","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1359\/JBMR.051017","volume":"21","author":"A Iida-Klein","year":"2006","unstructured":"Iida-Klein A, Hughes C, Lu SS, Moreno A, Shen V, Dempster DW, Cosman F, Lindsay R (2006) Effects of cyclic versus daily hPTH (1\u201334) regimens on bone strength in association with BMD, biochemical markers, and bone structure in mice. J Bone Miner Res 21:274\u2013282","journal-title":"J Bone Miner Res"},{"key":"9187_CR49","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3844\/ajisp.2006.40.51","volume":"2","author":"CJ Andresen","year":"2006","unstructured":"Andresen CJ, Olson E, Nduaka CI, Pero R, Bagi CM (2006) Action of calciotropic hormones on bone metabolism\u2014role of vitamin D3 in bone remodeling events. Am J Immunol 2:40\u201351","journal-title":"Am J Immunol"},{"key":"9187_CR50","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1002\/ar.1092260403","volume":"226","author":"HM Frost","year":"1990","unstructured":"Frost HM (1990) Structural adaptation to mechanical usage (SATMU). 1. Redefining Wolff\u2019s law: the bone remodeling problem. Anat Rec 226:414\u2013422","journal-title":"Anat Rec"}],"container-title":["Calcified Tissue International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-008-9187-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00223-008-9187-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-008-9187-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T11:37:55Z","timestamp":1558697875000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00223-008-9187-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11,18]]},"references-count":50,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["9187"],"URL":"https:\/\/doi.org\/10.1007\/s00223-008-9187-5","relation":{},"ISSN":["0171-967X","1432-0827"],"issn-type":[{"value":"0171-967X","type":"print"},{"value":"1432-0827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,11,18]]}}}